Business Opportunities and Investment Strategies for Global Pain Management Market 2023-2033

PrintEmail
April 2024 | 179 Pages | From $1,000
Description

The report cover may be different from the image shown.

  • The product will be delivered as a PDF file by Email within 48 business hours upon receiving an order. 
  • To learn more about the report, please Download General Sample Pages and Download Excel Datasheet SampleThe report will be updated before delivery, so that the most recent historic year is the base year and forecast covers 5-10 years over the base year.
  • Price of regional full report = price of global full report - $1,000.
  • Price of national full report = price of global full report - $1,800.
  • Price of tables/figures = $50 each.
  • Please Contact Us for any question, custom research, and current discount. It is possible now to buy a part of the report such as chapters, sections, data tables or figures.
  • For details about the license types, please refer to our Terms of Service 
Product and Price

By clicking the Add to Shopping Cart button, you certify to agree with our Terms of Service.

 

Opportunity and Strategy Analysis
This report focuses on identifying opportunities and strategies for investing in the global pain management market within the forecast period. It provides a complete analysis of the global market both quantitatively and qualitatively. The quantitative analysis includes market size and revenue data of the total demand, sub-markets, and regional/national levels throughout 2023-2033. Qualitative analysis depicts a full picture of market dynamics and trends including drivers, restraints and challenges, emerging products/market trends, and Porter’s Fiver Forces analysis.

Based on the market data and analysis, the report highlights Increasingly Attractive Segments (IAS) and business opportunities in each segmentation. Moreover, a systematic evaluation of Internal Risks (factors arising within the industry development) and External Risks (factors arising from the surrounding environments) is provided for the pain management industry and market. All the identified risk factors are measured quantitatively according to GMD’s novel numeric system, i.e. each risk is evaluated with GMD Risk Index Number (GMD RIN) and GMD Risk Intensity Level (GMD RIL). This in-depth risk assessment offers a comprehensive understanding of the current risk factors and their developing trends. Furthermore, this report concludes risk management strategies and Critical Success Factors (CSFs) to help companies make intelligence-based business decisions in the global pain management industry.

Market Coverage & Overview
The report is based on studies for 2021-2023 and provides a forecast from 2024 till 2033 with 2023 as the base year. Considering impact of COVID-19 and regional conflicts such as Russia-Ukraine war, the trend and outlook of global market is forecast in optimistic, balanced, and conservative scenarios. In the balanced view, the global pain management market is expected to reach $146.1 billion by 2033, growing by 5.6% annually over the coming years.

Segmentation Analysis
Highlighted with 90 tables and 92 figures, this 179-page report represents a 360-degree view on the global market with extensively detailed segmentations by Offering, Application, Distribution Channel, and Region/Country as shown below. Annual revenue 2023-2033 for each segment is included in the report.

By Offering
• Drugs
o Opioids
o NSAIDS
o Anesthetics
o Anticonvulsants
o Anti-depressants
o Non-narcotic Analgesics
• Devices
o Neurostimulation Devices
 Transcutaneous Electrical Nerve Stimulation (TENS) Devices
 Brain and Spinal Cord Stimulation (SCS) Devices
o Analgesic Infusion Pumps
 Intrathecal Infusion Pumps
 External Infusion Pumps

By Application
• Neuropathic Pain
• Cancer Pain
• Facial Pain and Migraine
• Musculoskeletal Pain
• Post-operative Pain
• Chronic Back Pain
• Arthritic Pain
• Other Applications

By Distribution Channel
• Hospitals Pharmacy
• Online Pharmacy
• Retail Pharmacy

By Region
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa, and Rest of MEA)
The breakdown of all regional markets by country and the breakdown of each national market by Offering, Application, and Distribution Channel over the forecast years are also included.

Key Companies
The report also covers the current competitive scenario and profiles key vendors including market leaders and important emerging players. A selection of companies profiled in this report includes:
• Abbott Laboratories Inc.
• Baxter International Inc.
• Becton, Dickinson and Company
• Boehringer Ingelheim International GmbH
• Boston Scientific Corporation
• Eli Lilly & Company
• Endo Health Solutions, Inc.
• Fresenius SE & Co. KGaA
• GlaxoSmithKline PLC
• Johnson & Johnson
• Medtronic PLC
• Merck & Co. Inc.
• Novartis AG
• Pfizer Inc.
• Purdue Pharma L.P
• Teva Pharmaceutical Industries Ltd.

Reasons to Purchase
• Gain a most comprehensive view on global market with lighting on market outlook, segmentations, dynamics and trends, growth opportunities, risk assessment, critical success factors (CSFs), increasingly attractive segments (IAS), and Porter’s Fiver Forces analysis.
• Access identified business opportunities and benchmarked investment strategies.
• Obtain up-to-date data and valuable insights to create regional and national strategies.
• Take wise actions to mitigate potential risk based on the matrix of systematic risk evaluation.
• Outperform competitors using the latest market data and research discoveries.
• Support internal and external presentations with reliable data and profound analysis.
• Backed up by premium primary and secondary information sources with inputs derived from industry professionals across the value chain.
• Supported by free customer services before and after sales.

Table of Contents

1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 25
2.1.3 Impact of Russia-Ukraine Conflict 27
2.1.4 Impact of Israel-Palestine War 29
2.2 Major Growth Drivers 30
2.3 Market Restraints and Challenges 35
2.4 Emerging Opportunities and Market Trends 38
2.5 Porter’s Fiver Forces Analysis 41
3 Segmentation of Global Market by Offering 45
3.1 Market Overview by Offering 45
3.2 Drugs 48
3.2.1 Opioids 50
3.2.2 NSAIDS 51
3.2.3 Anesthetics 52
3.2.4 Anticonvulsants 53
3.2.5 Anti-depressants 54
3.2.6 Non-narcotic Analgesics 55
3.3 Devices 56
3.3.1 Neurostimulation Devices 57
3.3.2 Analgesic Infusion Pumps 58
4 Segmentation of Global Market by Application 59
4.1 Market Overview by Application 59
4.2 Neuropathic Pain 62
4.3 Cancer Pain 63
4.4 Facial Pain and Migraine 64
4.5 Musculoskeletal Pain 65
4.6 Post-operative Pain 66
4.7 Chronic Back Pain 67
4.8 Arthritic Pain 68
4.9 Other Applications 69
5 Segmentation of Global Market by Distribution Channel 70
5.1 Market Overview by Distribution Channel 70
5.2 Hospitals Pharmacy 73
5.3 Online Pharmacy 74
5.4 Retail Pharmacy 75
6 Segmentation of Global Market by Region 76
6.1 Geographic Market Overview 2023-2033 76
6.2 North America Market 2023-2033 by Country 81
6.2.1 Overview of North America Market 81
6.2.2 U.S. 85
6.2.3 Canada 88
6.2.4 Mexico 90
6.3 European Market 2023-2033 by Country 92
6.3.1 Overview of European Market 92
6.3.2 Germany 96
6.3.3 U.K. 98
6.3.4 France 100
6.3.5 Spain 102
6.3.6 Italy 104
6.3.7 Russia 106
6.3.8 Rest of European Market 108
6.4 Asia-Pacific Market 2023-2033 by Country 110
6.4.1 Overview of Asia-Pacific Market 110
6.4.2 Japan 114
6.4.3 China 117
6.4.4 Australia 119
6.4.5 India 121
6.4.6 South Korea 123
6.4.7 Rest of APAC Region 125
6.5 South America Market 2023-2033 by Country 127
6.5.1 Argentina 131
6.5.2 Brazil 133
6.5.3 Chile 135
6.5.4 Rest of South America Market 137
6.6 MEA Market 2023-2033 by Country 138
6.6.1 UAE 142
6.6.2 Saudi Arabia 144
6.6.3 South Africa 146
6.6.4 Other National Markets 148
7 Competitive Landscape 149
7.1 Overview of Key Vendors 149
7.2 New Product Launch, Partnership, Investment, and M&A 152
7.3 Company Profiles 153
Abbott Laboratories Inc. 153
Baxter International Inc. 155
Becton, Dickinson and Company 156
Boehringer Ingelheim International GmbH 157
Boston Scientific Corporation 158
Eli Lilly & Company 159
Endo Health Solutions, Inc. 160
Fresenius SE & Co. KGaA 161
GlaxoSmithKline PLC 162
Johnson & Johnson 163
Medtronic PLC 164
Merck & Co. Inc. 165
Novartis AG 166
Pfizer Inc. 167
Purdue Pharma L.P 168
Teva Pharmaceutical Industries Ltd. 169
8 Investing in Pain Management Industry: Risk Assessment and Management 170
8.1 Risk Evaluation of Global Market 170
8.2 Critical Success Factors (CSFs) 176
RELATED REPORTS 179

List of Tables:

Table 1. Snapshot of Global Pain Management Market in Balanced Perspective, 2023-2033 19
Table 2. World Economic Outlook, 2024-2036 22
Table 3. World Economic Outlook, 2022-2024 24
Table 4. Scenarios for Economic Impact of Ukraine Crisis 28
Table 5. Scenarios for Economic Impact of Israel-Palestine War 29
Table 6. World Health Spending by Region, $ bn, 2013-2020 34
Table 7. Main Product Trends and Market Opportunities in Global Pain Management Market 38
Table 8. Global Pain Management Market by Offering, 2023-2033, $ mn 46
Table 9. Global Pain Management Market: Drugs by Type, 2023-2033, $ mn 49
Table 10. Global Pain Management Market: Devices by Type, 2023-2033, $ mn 56
Table 11. Global Pain Management Market: Neurostimulation Devices by Type, 2023-2033, $ mn 57
Table 12. Global Pain Management Market: Analgesic Infusion Pumps by Type, 2023-2033, $ mn 58
Table 13. Global Pain Management Market by Application, 2023-2033, $ mn 60
Table 14. Global Pain Management Market by Distribution Channel, 2023-2033, $ mn 71
Table 15. Global Pain Management Market by Region, 2023-2033, $ mn 78
Table 16. Leading National Pain Management Market, 2023 and 2033, $ mn 80
Table 17. North America Pain Management Market by Country, 2023-2033, $ mn 83
Table 18. U.S. Pain Management Market by Offering, 2023-2033, $ mn 87
Table 19. U.S. Pain Management Market by Application, 2023-2033, $ mn 87
Table 20. U.S. Pain Management Market by Distribution Channel, 2023-2033, $ mn 87
Table 21. Canada Pain Management Market by Offering, 2023-2033, $ mn 89
Table 22. Canada Pain Management Market by Application, 2023-2033, $ mn 89
Table 23. Canada Pain Management Market by Distribution Channel, 2023-2033, $ mn 89
Table 24. Mexico Pain Management Market by Offering, 2023-2033, $ mn 91
Table 25. Mexico Pain Management Market by Application, 2023-2033, $ mn 91
Table 26. Mexico Pain Management Market by Distribution Channel, 2023-2033, $ mn 91
Table 27. Europe Pain Management Market by Country, 2023-2033, $ mn 94
Table 28. Germany Pain Management Market by Offering, 2023-2033, $ mn 97
Table 29. Germany Pain Management Market by Application, 2023-2033, $ mn 97
Table 30. Germany Pain Management Market by Distribution Channel, 2023-2033, $ mn 97
Table 31. U.K. Pain Management Market by Offering, 2023-2033, $ mn 99
Table 32. U.K. Pain Management Market by Application, 2023-2033, $ mn 99
Table 33. U.K. Pain Management Market by Distribution Channel, 2023-2033, $ mn 99
Table 34. France Pain Management Market by Offering, 2023-2033, $ mn 101
Table 35. France Pain Management Market by Application, 2023-2033, $ mn 101
Table 36. France Pain Management Market by Distribution Channel, 2023-2033, $ mn 101
Table 37. Spain Pain Management Market by Offering, 2023-2033, $ mn 103
Table 38. Spain Pain Management Market by Application, 2023-2033, $ mn 103
Table 39. Spain Pain Management Market by Distribution Channel, 2023-2033, $ mn 103
Table 40. Italy Pain Management Market by Offering, 2023-2033, $ mn 105
Table 41. Italy Pain Management Market by Application, 2023-2033, $ mn 105
Table 42. Italy Pain Management Market by Distribution Channel, 2023-2033, $ mn 105
Table 43. Russia Pain Management Market by Offering, 2023-2033, $ mn 107
Table 44. Russia Pain Management Market by Application, 2023-2033, $ mn 107
Table 45. Russia Pain Management Market by Distribution Channel, 2023-2033, $ mn 107
Table 46. Pain Management Market in Rest of Europe by Country, 2023-2033, $ mn 109
Table 47. APAC Pain Management Market by Country, 2023-2033, $ mn 112
Table 48. Japan Pain Management Market by Offering, 2023-2033, $ mn 116
Table 49. Japan Pain Management Market by Application, 2023-2033, $ mn 116
Table 50. Japan Pain Management Market by Distribution Channel, 2023-2033, $ mn 116
Table 51. China Pain Management Market by Offering, 2023-2033, $ mn 118
Table 52. China Pain Management Market by Application, 2023-2033, $ mn 118
Table 53. China Pain Management Market by Distribution Channel, 2023-2033, $ mn 118
Table 54. Australia Pain Management Market by Offering, 2023-2033, $ mn 120
Table 55. Australia Pain Management Market by Application, 2023-2033, $ mn 120
Table 56. Australia Pain Management Market by Distribution Channel, 2023-2033, $ mn 120
Table 57. India Pain Management Market by Offering, 2023-2033, $ mn 122
Table 58. India Pain Management Market by Application, 2023-2033, $ mn 122
Table 59. India Pain Management Market by Distribution Channel, 2023-2033, $ mn 122
Table 60. South Korea Pain Management Market by Offering, 2023-2033, $ mn 124
Table 61. South Korea Pain Management Market by Application, 2023-2033, $ mn 124
Table 62. South Korea Pain Management Market by Distribution Channel, 2023-2033, $ mn 124
Table 63. Pain Management Market in Rest of APAC by Country/Region, 2023-2033, $ mn 126
Table 64. South America Pain Management Market by Country, 2023-2033, $ mn 129
Table 65. Argentina Pain Management Market by Offering, 2023-2033, $ mn 132
Table 66. Argentina Pain Management Market by Application, 2023-2033, $ mn 132
Table 67. Argentina Pain Management Market by Distribution Channel, 2023-2033, $ mn 132
Table 68. Brazil Pain Management Market by Offering, 2023-2033, $ mn 134
Table 69. Brazil Pain Management Market by Application, 2023-2033, $ mn 134
Table 70. Brazil Pain Management Market by Distribution Channel, 2023-2033, $ mn 134
Table 71. Chile Pain Management Market by Offering, 2023-2033, $ mn 136
Table 72. Chile Pain Management Market by Application, 2023-2033, $ mn 136
Table 73. Chile Pain Management Market by Distribution Channel, 2023-2033, $ mn 136
Table 74. MEA Pain Management Market by Country, 2023-2033, $ mn 140
Table 75. UAE Pain Management Market by Offering, 2023-2033, $ mn 143
Table 76. UAE Pain Management Market by Application, 2023-2033, $ mn 143
Table 77. UAE Pain Management Market by Distribution Channel, 2023-2033, $ mn 143
Table 78. Saudi Arabia Pain Management Market by Offering, 2023-2033, $ mn 145
Table 79. Saudi Arabia Pain Management Market by Application, 2023-2033, $ mn 145
Table 80. Saudi Arabia Pain Management Market by Distribution Channel, 2023-2033, $ mn 145
Table 81. South Africa Pain Management Market by Offering, 2023-2033, $ mn 147
Table 82. South Africa Pain Management Market by Application, 2023-2033, $ mn 147
Table 83. South Africa Pain Management Market by Distribution Channel, 2023-2033, $ mn 147
Table 84. Abbott Laboratories Inc.: Company Snapshot 153
Table 85. Abbott Laboratories Inc.: Business Segmentation 154
Table 86. Abbott Laboratories Inc.: Product Portfolio 154
Table 87. List of Risk Factors and Weight Percentages/Theoretical Maximum 171
Table 88. Definition of GMD Relative Risk Index Number (Relative RIN) and GMD Risk Intensity Level (RIL) 172
Table 89. Risk Evaluation for Investing in Global Market, 2023-2033 173
Table 90. Critical Success Factors and Key Takeaways 177

List of Figures:

Figure 1. Research Method Flow Chart 13
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 16
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2023-2033 18
Figure 4. Global Pain Management Market, 2023-2033, $ mn 20
Figure 5. Impact of COVID-19 on Business 25
Figure 6. Primary Drivers and Impact Factors of Global Pain Management Market 30
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 33
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 33
Figure 9. Primary Restraints and Impact Factors of Global Pain Management Market 35
Figure 10. Porter’s Fiver Forces Analysis of Global Pain Management Market 41
Figure 11. Growth Opportunity Analysis by Offering 45
Figure 12. Breakdown of Global Pain Management Market by Offering, 2023-2033, % of Revenue 46
Figure 13. Global Addressable Market Cap in 2024-2033 by Offering, Value ($ mn) and Share (%) 47
Figure 14. Global Pain Management Market by Offering: Drugs, 2023-2033, $ mn 48
Figure 15. Global Pain Management Market by Drugs: Opioids, 2023-2033, $ mn 50
Figure 16. Global Pain Management Market by Drugs: NSAIDS, 2023-2033, $ mn 51
Figure 17. Global Pain Management Market by Drugs: Anesthetics, 2023-2033, $ mn 52
Figure 18. Global Pain Management Market by Drugs: Anticonvulsants, 2023-2033, $ mn 53
Figure 19. Global Pain Management Market by Drugs: Anti-depressants, 2023-2033, $ mn 54
Figure 20. Global Pain Management Market by Drugs: Non-narcotic Analgesics, 2023-2033, $ mn 55
Figure 21. Global Pain Management Market by Offering: Devices, 2023-2033, $ mn 56
Figure 22. Global Pain Management Market by Devices: Neurostimulation Devices, 2023-2033, $ mn 57
Figure 23. Global Pain Management Market by Devices: Analgesic Infusion Pumps, 2023-2033, $ mn 58
Figure 24. Growth Opportunity Analysis by Application 59
Figure 25. Breakdown of Global Pain Management Market by Application, 2023-2033, % of Sales Revenue 60
Figure 26. Global Addressable Market Cap in 2024-2033 by Application, Value ($ mn) and Share (%) 61
Figure 27. Global Pain Management Market by Application: Neuropathic Pain, 2023-2033, $ mn 62
Figure 28. Global Pain Management Market by Application: Cancer Pain, 2023-2033, $ mn 63
Figure 29. Global Pain Management Market by Application: Facial Pain and Migraine, 2023-2033, $ mn 64
Figure 30. Global Pain Management Market by Application: Musculoskeletal Pain, 2023-2033, $ mn 65
Figure 31. Global Pain Management Market by Application: Post-operative Pain, 2023-2033, $ mn 66
Figure 32. Global Pain Management Market by Application: Chronic Back Pain, 2023-2033, $ mn 67
Figure 33. Global Pain Management Market by Application: Arthritic Pain, 2023-2033, $ mn 68
Figure 34. Global Pain Management Market by Application: Other Applications, 2023-2033, $ mn 69
Figure 35. Growth Opportunity Analysis by Distribution Channel 70
Figure 36. Breakdown of Global Pain Management Market by Distribution Channel, 2023-2033, % of Revenue 71
Figure 37. Global Addressable Market Cap in 2024-2033 by Distribution Channel, Value ($ mn) and Share (%) 72
Figure 38. Global Pain Management Market by Distribution Channel: Hospitals Pharmacy, 2023-2033, $ mn 73
Figure 39. Global Pain Management Market by Distribution Channel: Online Pharmacy, 2023-2033, $ mn 74
Figure 40. Global Pain Management Market by Distribution Channel: Retail Pharmacy, 2023-2033, $ mn 75
Figure 41. Global Market Snapshot by Region 76
Figure 42. Growth Opportunity Analysis of Global Market by Region 77
Figure 43. Geographic Spread of Worldwide Pain Management Market, 2023-2033, % of Sales Revenue 78
Figure 44. Global Addressable Market Cap in 2024-2033 by Region, Value ($ mn) and Share (%) 79
Figure 45. North American Pain Management Market, 2023-2033, $ mn 82
Figure 46. Growth Opportunity Analysis of North America Market by Country 82
Figure 47. Breakdown of North America Pain Management Market by Country, 2023 and 2033, % of Revenue 83
Figure 48. Contribution to North America 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 84
Figure 49. U.S. Pain Management Market, 2023-2033, $ mn 86
Figure 50. Canada Pain Management Market, 2023-2033, $ mn 88
Figure 51. Pain Management Market in Mexico, 2023-2033, $ mn 90
Figure 52. European Pain Management Market, 2023-2033, $ mn 93
Figure 53. Growth Opportunity Analysis of Europe Market by Country 93
Figure 54. Breakdown of European Pain Management Market by Country, 2023 and 2033, % of Revenue 94
Figure 55. Contribution to Europe 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 95
Figure 56. Pain Management Market in Germany, 2023-2033, $ mn 96
Figure 57. Pain Management Market in U.K., 2023-2033, $ mn 98
Figure 58. Pain Management Market in France, 2023-2033, $ mn 100
Figure 59. Pain Management Market in Spain, 2023-2033, $ mn 102
Figure 60. Pain Management Market in Italy, 2023-2033, $ mn 104
Figure 61. Pain Management Market in Russia, 2023-2033, $ mn 106
Figure 62. Pain Management Market in Rest of Europe, 2023-2033, $ mn 108
Figure 63. Asia-Pacific Pain Management Market, 2023-2033, $ mn 111
Figure 64. Growth Opportunity Analysis of Asia-Pacific Market by Country 111
Figure 65. Breakdown of APAC Pain Management Market by Country, 2023 and 2033, % of Revenue 112
Figure 66. Contribution to APAC 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 113
Figure 67. Pain Management Market in Japan, 2023-2033, $ mn 115
Figure 68. Pain Management Market in China, 2023-2033, $ mn 117
Figure 69. Pain Management Market in Australia, 2023-2033, $ mn 119
Figure 70. Pain Management Market in India, 2023-2033, $ mn 121
Figure 71. Pain Management Market in South Korea, 2023-2033, $ mn 123
Figure 72. Pain Management Market in Rest of APAC, 2023-2033, $ mn 125
Figure 73. South America Pain Management Market, 2023-2033, $ mn 128
Figure 74. Growth Opportunity Analysis of South America Market by Country 128
Figure 75. Breakdown of South America Pain Management Market by Country, 2023 and 2033, % of Revenue 129
Figure 76. Contribution to South America 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 130
Figure 77. Pain Management Market in Argentina, 2023-2033, $ mn 131
Figure 78. Pain Management Market in Brazil, 2023-2033, $ mn 133
Figure 79. Pain Management Market in Chile, 2023-2033, $ mn 135
Figure 80. Pain Management Market in Rest of South America, 2023-2033, $ mn 137
Figure 81. Pain Management Market in Middle East and Africa (MEA), 2023-2033, $ mn 139
Figure 82. Growth Opportunity Analysis of MEA Market by Country 139
Figure 83. Breakdown of MEA Pain Management Market by Country, 2023 and 2033, % of Revenue 140
Figure 84. Contribution to MEA 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 141
Figure 85. Pain Management Market in UAE, 2023-2033, $ mn 142
Figure 86. Pain Management Market in Saudi Arabia, 2023-2033, $ mn 144
Figure 87. Pain Management Market in South Africa, 2023-2033, $ mn 146
Figure 88. Pain Management Market in the Rest of MEA, 2023-2033, $ mn 148
Figure 89. Growth Stage of Global Pain Management Industry over the Forecast Period 149
Figure 90. Comparison of Risk Factors by GMD RIN in 2023 173
Figure 91. GMD Relative RIN of Internal Risk Factors in 2023 on Radar Chart 174
Figure 92. GMD Relative RIN of External Risk Factors in 2023 on Radar Chart 174

Reviews

There are yet no reviews for this product.